Peled Amnon 4
4 · Silexion Therapeutics Corp · Filed Dec 31, 2025
Insider Transaction Report
Form 4
Peled Amnon
Director
Transactions
- Award
Ordinary Shares
2025-02-09+661→ 661 total - Award
Stock Option (right to buy Ordinary Shares)
2025-02-09+780→ 780 totalExercise: $18.90From: 2026-02-09Exp: 2035-02-09→ Ordinary Shares (780 underlying)
Footnotes (4)
- [F1]Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer, as consideration for the Reporting Person's service on the Issuer's board of directors. The shares subject to this award vest in full on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date.
- [F2]The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025.
- [F3]The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025.
- [F4]All of the stock options reported in this row vest (and become exercisable) on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date.